Bioreactors Fermenters Market

Bioreactors and Fermenters Market (Product - Single-use Bioreactors and Multiple-use Bioreactors; Process - Fed Batch and Continuous Batch; End User - Biopharmaceutical Companies, CROs, and Academic and Research Institutes) - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024

  • Rep Id : TMRGL15230
  • Published On : May 2017
  • No. of Pages : 182
  • Category : Healthcare

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Bioreactors and Fermenters Market

4. Market Overview
     4.1. Introduction
     4.2. Overview
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunity
     4.4. Global Bioreactors and Fermenters Market Analysis and Forecasts, 2016–2024
            4.4.1. Market Volume Projections
     4.5. Bioreactors and Fermenters Market - Global Supply Demand Scenario
     4.6. Porter’s Five Force Analysis
     4.7. Value Chain Analysis
            4.7.1. List of active market participants 
     4.8. Market Outlook

5. Global Bioreactors and Fermenters Market Analysis and Forecasts, By Product 
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Value Forecast By Product
            5.4.1. Single-use bioreactors
            5.4.2. Multi-use bioreactors
     5.5. Market Attractiveness By Product 

6. Global Bioreactors and Fermenters Market Analysis and Forecasts, By Process 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market Value Forecast By Process
            6.4.1. Fed batch
            6.4.2. Continuous
            6.4.3. Batch
     6.5. Market Attractiveness By Process 

7. Global Bioreactors and Fermenters Market Analysis and Forecasts, By End-User 
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Key Trends
     7.4. Market Value Forecast By End-User 
            7.4.1. Biopharmaceutical companies
            7.4.2. CROs
            7.4.3. Academic & Research Institutes
     7.5. Market Attractiveness By End-User 

8. Global Bioreactors and Fermenters Market Analysis and Forecasts, By Region
     8.1. Key Findings
     8.2. Market Value Forecast By Region
            8.2.1. North America 
            8.2.2. Europe 
            8.2.3. Asia Pacific 
            8.2.4. Latin America 
            8.2.5. Middle East and Africa 
     8.3. Market Attractiveness By Country/Region

9. North America Bioreactors and Fermenters Market Analysis and Forecast
     9.1. Introduction
            9.1.1. Key Findings
            9.1.2. Key Trends
     9.2. Market Value Forecast By Product 
            9.2.1. Single-use bioreactors
            9.2.2. Multi-use bioreactors
     9.3. Market Value Forecast By Process 
            9.3.1. Fed batch
            9.3.2. Continuous
            9.3.3. Batch
     9.4. Market Value Forecast By End-User 
            9.4.1. Biopharmaceutical companies
            9.4.2. CROs
            9.4.3. Academic & Research Institutes
     9.5. Market Value Forecast By Country 
            9.5.1. U.S.
            9.5.2. Canada
     9.6. Market Attractiveness Analysis 

10. Europe Bioreactors and Fermenters Market Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
            10.1.2. Key Trends
     10.2. Market Value Forecast By Product 
            10.2.1. Single-use bioreactors
            10.2.2. Multi-use bioreactors
     10.3. Market Value Forecast By Process 
            10.3.1. Fed batch
            10.3.2. Continuous
            10.3.3. Batch
     10.4. Market Value Forecast By End-User , 2014–2024
            10.4.1. Biopharmaceutical companies
            10.4.2. CROs
            10.4.3. Academic & Research Institutes
     10.5. Market Value Forecast By Country , 2014–2024
            10.5.1. Germany 
            10.5.2. France 
            10.5.3. U.K. 
            10.5.4. Rest of Europe
     10.6. Market Attractiveness Analysis 

11. Asia Pacific Bioreactors and Fermenters Market Analysis and Forecast
     11.1. Introduction
            11.1.1. Key Findings
            11.1.2. Key Trends
     11.2. Market Value Forecast By Product 
            11.2.1. Single-use bioreactors
            11.2.2. Multi-use bioreactors
     11.3. Market Value Forecast By Process 
            11.3.1. Fed batch
            11.3.2. Continuous
            11.3.3. Batch
     11.4. Market Value Forecast By End-User 
            11.4.1. Biopharmaceutical companies
            11.4.2. CROs
            11.4.3. Academic & Research Institutes
     11.5. Market Value Forecast By Country 
            11.5.1. Japan 
            11.5.2. China 
            11.5.3. India 
            11.5.4. Australia 
            11.5.5. Rest of Asia Pacific
     11.6. Market Attractiveness Analysis 

12. Latin America Bioreactors and Fermenters Market Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
            12.1.2. Key Trends
     12.2. Market Value Forecast By Product 
            12.2.1. Single-use bioreactors
            12.2.2. Multi-use bioreactors
     12.3. Market Value Forecast By Process 
            12.3.1. Fed batch
            12.3.2. Continuous
            12.3.3. Batch
     12.4. Market Value Forecast By End-User 
            12.4.1. Biopharmaceutical companies
            12.4.2. CROs
            12.4.3. Academic & Research Institutes
     12.5. Market Value Forecast By Country 
            12.5.1. Brazil 
            12.5.2. Mexico 
            12.5.3. Rest of Latin America
     12.6. Market Attractiveness Analysis 

13. Middle East and Africa Bioreactors and Fermenters Market Analysis and Forecast
     13.1. Introduction
            13.1.1. Key Findings
            13.1.2. Key Trends
     13.2. Market Value Forecast By Product 
            13.2.1. Single-use bioreactors
            13.2.2. Multi-use bioreactors
     13.3. Market Value Forecast By Process 
            13.3.1. Fed batch
            13.3.2. Continuous
            13.3.3. Batch
     13.4. Market Value Forecast By End-User 
            13.4.1. Biopharmaceutical companies
            13.4.2. CROs
            13.4.3. Academic & Research Institutes
     13.5. Market Value Forecast By Country 
            13.5.1. Saudi Arabia 
            13.5.2. South Africa 
            13.5.3. Rest of MEA
     13.6. Market Attractiveness Analysis 

14. Competition Landscape
     14.1. Market Player – Competition Matrix (By Tier and Size of companies)
     14.2. Market Share Analysis By Company (2015)
     14.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            14.3.1. Applikon Biotechnology B.V. 
                     14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.1.2. Business Overview
                     14.3.1.3. Product Portfolio 
                     14.3.1.4. Financial Overview 
                     14.3.1.5. SWOT Analysis 
                     14.3.1.6. Strategic overview
            14.3.2. Danaher Corporation
                     14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.2.2. Business Overview
                     14.3.2.3. Product Portfolio 
                     14.3.2.4. Financial Overview 
                     14.3.2.5. SWOT Analysis 
                     14.3.2.6. Strategic overview
            14.3.3. Eppendorf AG
                     14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.3.2. Business Overview
                     14.3.3.3. Product Portfolio 
                     14.3.3.4. Financial Overview 
                     14.3.3.5. SWOT Analysis 
                     14.3.3.6. Strategic overview 
            14.3.4. Finesse Solutions, Inc. 
                     14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.4.2. Business Overview
                     14.3.4.3. Product Portfolio 
                     14.3.4.4. Financial Overview 
                     14.3.4.5. SWOT Analysis 
                     14.3.4.6. Strategic overview
            14.3.5. GE Healthcare
                     14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.5.2. Business Overview
                     14.3.5.3. Product Portfolio 
                     14.3.5.4. Financial Overview 
                     14.3.5.5. SWOT Analysis 
                     14.3.5.6. Strategic overview
            14.3.6. Merck KGaA
                     14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.6.2. Business Overview
                     14.3.6.3. Product Portfolio 
                     14.3.6.4. Financial Overview 
                     14.3.6.5. SWOT Analysis 
                     14.3.6.6. Strategic overview 
            14.3.7. PBS Biotech, Inc.
                     14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.7.2. Business Overview
                     14.3.7.3. Product Portfolio 
                     14.3.7.4. Financial Overview 
                     14.3.7.5. SWOT Analysis 
                     14.3.7.6. Strategic overview
            14.3.8. PIERRE GUERIN TECHNOLOGIES
                     14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.8.2. Business Overview
                     14.3.8.3. Product Portfolio 
                     14.3.8.4. Financial Overview 
                     14.3.8.5. SWOT Analysis 
                     14.3.8.6. Strategic overview
            14.3.9. Sartorius AG
                     14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.9.2. Business Overview
                     14.3.9.3. Product Portfolio 
                     14.3.9.4. Financial Overview 
                     14.3.9.5. SWOT Analysis 
                     14.3.9.6. Strategic overview
            14.3.10. SOLARIS BIOTECHNOLOGY srl
                     14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.10.2. Business Overview
                     14.3.10.3. Product Portfolio 
                     14.3.10.4. Financial Overview 
                     14.3.10.5. SWOT Analysis 
                     14.3.10.6. Strategic overview
            14.3.11. Thermo Fisher Scientific Inc
                     14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.11.2. Business Overview
                     14.3.11.3. Product Portfolio 
                     14.3.11.4. Financial Overview 
                     14.3.11.5. SWOT Analysis 
                     14.3.11.6. Strategic overview 
            14.3.12. ZETA Holding GmbH
                     14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.3.12.2. Business Overview
                     14.3.12.3. Product Portfolio 
                     14.3.12.4. Financial Overview 
                     14.3.12.5. SWOT Analysis 
                     14.3.12.6. Strategic overview

List of Tables

Table 01: Global Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Product Type, 2016–2024
Table 02: Global Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Process Type, 2016–2024
Table 03: Global Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by End user, 2016–2024
Table 04: Global Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Region, 2016–2024
Table 05: North America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Product, 2016–2024
Table 06: North America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Process, 2016–2024
Table 07: North America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by End user, 2016–2024
Table 08: North America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 09: Europe Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Product, 2016–2024
Table 10: Europe Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Process, 2016–2024
Table 11: Europe Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by End user, 2016–2024
Table 12: Europe Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 13: Asia Pacific Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Product, 2016–2024
Table 14: Asia Pacific Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Process, 2016–2024
Table 15: Asia Pacific Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by End user, 2016–2024
Table 16: Asia Pacific Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 17: Latin America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Product, 2016–2024
Table 18: Latin America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Process, 2016–2024
Table 19: Latin America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by End user, 2016–2024
Table 20: Latin America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 21: Middle East and Africa Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Product, 2016–2024
Table 22: Middle East and Africa Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Process, 2016–2024
Table 23: Middle East and Africa Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by End user, 2016–2024
Table 24: Middle East and Africa Bioreactors and Fermenters Market Size (US$ Mn) Forecast, by Country, 2016–2024

List of Figures

Figure 01: Global Bioreactors and Fermenters Market Size (US$ Mn) Forecast, 2016–2024
Figure 02: Global Bioreactors and Fermenters Market Value Share Analysis, by Product Type, 2016 and 2024
Figure 03: Global Single-use Bioreactors Market Revenue (US$ Mn), 2015-2024
Figure 04: Global Multiple-use Bioreactors Market Revenue, US$ Mn, 2015–2024
Figure 05: Bioreactors and Fermenters Market Attractiveness Analysis By Product Type
Figure 06: Global Bioreactors and Fermenters Market Value Share Analysis By Process Type, 2016 and 2024
Figure 07: Fed batch Bioreactors Market Revenue, US$ Mn, 2014–2024
Figure 08: Global Continuous Process Bioreactors Market Revenue, US$ Mn, 2014–2024
Figure 09: Global Batch Process Bioreactors Market Revenue, US$ Mn, 2014–2024
Figure 10: Global Bioreactors and Fermenters Market Attractiveness Analysis, By Process Type
Figure 11: Global Bioreactors and Fermenters Market Value Share Analysis By End users, 2016 and 2024
Figure 12: Global Biopharmaceutical companies Market Revenue (US$ Mn), 2016–2024
Figure 13: Global CROs Market Revenue (US$ Mn), 2016–2024
Figure 14: Global Academic & Research Institutes Market Revenue (US$ Mn), 2016–2024
Figure 15: Bioreactors and Fermenters Market Attractiveness Analysis, by End user
Figure 16: Global Bioreactors and Fermenters Market Analysis By Region, 2016 and 2024
Figure 17: Global Bioreactors and Fermenters Market Attractiveness Analysis, By Region Type
Figure 18: North America Bioreactors and Fermenters  Market Size (US$ Mn) Forecast, 2016–2024
Figure 19: North America Market Attractiveness Analysis By Country
Figure 20: North America Bioreactors and Fermenters Market Value Share Analysis By Product Type, 2016 and 2024
Figure 21: North America Bioreactors and Fermenters Market Value Share Analysis By Process Type, 2016 and 2024
Figure 22: North America Bioreactors and Fermenters Market Value Share Analysis By End User Type, 2016 and 2024
Figure 23: North America Market Value Share Analysis By Country, 2016 and 2024
Figure 24: North America Market Attractiveness Analysis, by Product 
Figure 25: North America Market Attractiveness Analysis, by Process
Figure 26: North America Market Attractiveness Analysis, by End User
Figure 27: Europe Bioreactors and Fermenters Market Size (US$ Mn) Forecast, 2016–2024
Figure 28: Europe Market Attractiveness Analysis, by Country
Figure 29: Europe Market Value Share Analysis By Product Type, 2016 and 2024
Figure 30: Europe Market Value Share Analysis By Process Type, 2016 and 2024
Figure 31: Europe Bioreactors and Fermenters Market Value Share Analysis By End User Type, 2016 and 2024
Figure 32: Europe Market Value Share Analysis, by Country, 2016 and 2024
Figure 33: Europe Market Attractiveness Analysis, by Product
Figure 34: Europe Market Attractiveness Analysis, by Process
Figure 35: Europe Market Attractiveness Analysis, by End User
Figure 36: Asia Pacific Bioreactors and Fermenters Market Size (US$ Mn) Forecast, 2016–2024
Figure 37: Asia Pacific Market Attractiveness Analysis, by Country
Figure 38: Asia Pacific Market Value Share Analysis By Product Type, 2016 and 2024
Figure 39: Asia Pacific Market Value Share Analysis By Process Type, 2016 and 2024
Figure 40: Asia Pacific Bioreactors and Fermenters Market Value Share Analysis By End User Type, 2016 and 2024
Figure 41: Asia Pacific Market Value Share Analysis, by Country, 2016 and 2024
Figure 42: Asia Pacific Market Attractiveness Analysis, by Product 
Figure 43: Asia Pacific Market Attractiveness Analysis, by Process
Figure 44: Asia Pacific Market Attractiveness Analysis, by End User
Figure 45: Latin America Bioreactors and Fermenters Market Size (US$ Mn) Forecast, 2016–2024
Figure 46: Latin America Market Attractiveness Analysis, by Country
Figure 47: Latin America Market Value Share Analysis By Product Type, 2016 and 2024
Figure 48: Latin America Market Value Share Analysis By Process Type, 2016 and 2024
Figure 49: Latin America Bioreactors and Fermenters Market Value Share Analysis By End User Type, 2016 and 2024
Figure 50: Latin America Market Value Share Analysis, by Country, 2016 and 2024
Figure 51: Latin America Market Attractiveness Analysis, by Product 
Figure 52: Latin America Market Attractiveness Analysis, by Process
Figure 53: Latin America Market Attractiveness Analysis, by End User
Figure 54: Middle East and Africa Bioreactors and Fermenters Market Size (US$ Mn) Forecast, 2016–2024
Figure 55: Middle East and Africa Market Attractiveness Analysis, by Country
Figure 56: Middle East and Africa Market Value Share Analysis By Product Type, 2016 and 2024
Figure 57: Middle East and Africa Market Value Share Analysis By Process Type, 2016 and 2024
Figure 58: Middle East and Africa Bioreactors and Fermenters Market Value Share Analysis By End User Type, 2016 and 2024
Figure 59: Middle East and Africa Market Value Share Analysis, by Country, 2016 and 2024
Figure 60: Middle East and Africa Market Attractiveness Analysis, by Product 
Figure 61: Middle East and Africa Market Attractiveness Analysis, by Process
Figure 62: Middle East and Africa Market Attractiveness Analysis, by End User
Figure 63: Global Bioreactors and Fermenters Market Share Analysis By Company (2015)